Lotte Biologics chief
James Park, CEO of Lotte Biologics Co., the biotech arm of Lotte Group, attends a press conference in Yokohama, south of Tokyo, on Oct. 9, 2025, on the sidelines of Bio Japan 2025. (Yonhap)
(END)
(C) Yonhap News Agency. All Rights Reserved